Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 11, 2000, Pages 4113-4117

  Tahara, Hideki ^a   Imanishi, Yasuo ^a   Yamada, Tomomi ^a   Tsujimoto, Yoshihiro ^b   Tabata, Tsutomu ^b   Inoue, Takashi ^b   Inaba, Masaaki ^a   Morii, Hirotoshi ^a   Nishizawa, Yoshiki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Inoue Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; CARCINOGENESIS; CHROMOSOME 11Q; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA FLANKING REGION; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE INACTIVATION; GENE LOCUS; GENE SEQUENCE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PATHOGENESIS; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; SINGLE STRAND CONFORMATION POLYMORPHISM; UREMIA;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; EXONS; FEMALE; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; HYPERPARATHYROIDISM; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PARATHYROID GLANDS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; UREMIA;

EID: 0034533967     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.11.4113     Document Type: Article

References (30)

1. Mono clonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia
2. Positional cloning of the gene for multiple endocrine neoplasia-type 1
3. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11
4. Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism
5. Genetic abnormalities in parathyroid nodules of uremic patients
6. Novel clonal chromosomal defects identified by comparative genomic hybridization and molecular allelotyping in refractory hyperparathyroidism of uremia
7. Short and long-term efficacy of total parathyroidectomy with immediate autographing compared with subtotal parathyroidectomy in hemodialysis patients
8. Tumors of the parathyroid gland
9. Parathyroid hyperplasia in tertiary hyperparathyroidism: A pathological and immunohistochemical reappraisal
10. A comprehensive genetic map of the human genome based on 5,264 microsatellites
11. Shadow bands seen when typing polymorphic dinucleotide repeats: Some causes and cures
12. Frequent loss of chromosome arm 1p DNA in parathyroid adenomas
13. Somatic mutation of the MEN1 gene in parathyroid tumours
14. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism
15. MEN1 gene mutations in refractory hyperparathyroidism of uremia
16. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/ MTS1 in human cancers
17. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma
18. CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene
19. Silencing o f the E-cadherin invasion suppressor gene by CpG methylation in human carcinomas
20. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation
21. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors
22. The cyclin D1/PRAD1 oncogene in human neoplasia
23. Cyclin D1/PRAD1 expression in parathyroid adenomas: An immunohistochemical study
24. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2
25. Loss of the retinoblastoma tumor suppressor gene in parathyroid carcinoma
26. p53 abnormalities in human parathyroid carcinoma
27. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma
28. Structural analysis of gene marker loci on chromosomes 10 and 11 in primary and secondary uraemic hyperparathyroidism
29. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas
30. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas